Frequency and its Associated Factors of Proteinuria Among Women having Preeclampsia with Hypertensive Disorders in Pregnancy at Khyber Teaching Hospital (KTH) Peshawar

Asma Ambareen; Tayyaba Mazhar; Ateeq Ur Rehman; Sania Nosheen; Farid Hussain

doi:10.70749/ijbr.v3i1.425

Authors

Asma Ambareen Department of Obstetrics & Gynecology, Khyber Teaching Hospital, Peshawar, KP, Pakistan.
Tayyaba Mazhar Department of Obstetrics & Gynecology, Khyber Teaching Hospital, Peshawar, KP, Pakistan.
Ateeq Ur Rehman District Headquarter Teaching Hospital, Kohat Development Authority, Kohat, KP, Pakistan.
Sania Nosheen Department of Obstetrics and Gynecology, Health Department, Peshawar, KP, Pakistan.
Farid Hussain District Headquarter Teaching Hospital, Kohat Development Authority, Kohat, KP, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v3i1.425

Keywords:

Proteinuria, Preeclampsia, Hypertensive Disorders, Ectopic Pregnancy

Abstract

Background: Hypertensive disorders during pregnancy pose substantial risks to both maternal and fetal health. Preeclampsia, characterized by new-onset hypertension and proteinuria, represents a significant global health concern with varying regional prevalence. Objective: This study aims to address the critical knowledge gap regarding the frequency and associated factors of proteinuria among women with Preeclampsia and Hypertensive Disorders in Pregnancy. Materials and Methods: In this cross sectional study, the gestational age was determined by either dates or first-trimester scans. Blood pressure measurements were taken, and Preeclampsia was diagnosed using established criteria. Urine samples were collected and analyzed for proteinuria. Patients were further screened for systemic lupus erythematosus and diabetes mellitus. Exclusion criteria included multiple pregnancies, chronic hypertension, renal disease, and chronic diabetes mellitus. Data were analyzed using SPSS version 22, and statistical significance was set at p ≤ 0.05. Results: Of the 137 participants, 54 (39.4%) were primiparous, and 83 (60.6%) were multiparous. The average age was 31.26 years with a range of 17-45 years. Proteinuria was detected in 26 (18.98%) patients. Proteinuria prevalence did not significantly vary by age group. However, its occurrence was notably higher in severe hypertensive patients (46.2%) and those with comorbidities such as diabetes (58.1%) and systemic lupus erythematosus (100%). Parity did not emerge as a decisive factor. Conclusion: Approximately 19% of the studied participants exhibited proteinuria, emphasizing the need for vigilant management and targeted interventions for high-risk pregnancies. While age showed limited influence, the severity of hypertension strongly correlated with proteinuria. Comorbidities, especially diabetes and systemic lupus erythematosus, significantly elevated the risk. Parity, however, did not emerge as a decisive factor.

Downloads

Download data is not yet available.

References

Bromfield, S. G., Ma, Q., DeVries, A., Inglis, T. C., & Gordon, A. (2023). The association between hypertensive disorders during pregnancy and maternal and neonatal outcomes: a retrospective claims analysis. BMC Pregnancy and Childbirth, 23(1). https://doi.org/10.1186/s12884-023-05818-9

Tomimatsu, T., Mimura, K., Matsuzaki, S., Endo, M., Kumasawa, K., & Kimura, T. (2019). Preeclampsia: Maternal systemic vascular disorder caused by generalized endothelial dysfunction due to placental Antiangiogenic factors. International Journal of Molecular Sciences, 20(17), 4246. https://doi.org/10.3390/ijms20174246

Craici, I. M., Wagner, S. J., Weissgerber, T. L., Grande, J. P., & Garovic, V. D. (2014). Advances in the pathophysiology of pre-eclampsia and related podocyte injury. Kidney International, 86(2), 275-285. https://doi.org/10.1038/ki.2014.17

Kenny, L., English, F., & McCarthy, F. (2015). Risk factors and effective management of preeclampsia. Integrated Blood Pressure Control, 7. https://doi.org/10.2147/ibpc.s50641

Smith, J. M., Lowe, R. F., Fullerton, J., Currie, S. M., Harris, L., & Felker-Kantor, E. (2013). An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management. BMC Pregnancy and Childbirth, 13(1). https://doi.org/10.1186/1471-2393-13-34

Giachini, F. R., Galaviz-Hernandez, C., Damiano, A. E., Viana, M., Cadavid, A., Asturizaga, P., Teran, E., Clapes, S., Alcala, M., Bueno, J., Calderón-Domínguez, M., Ramos, M. P., Lima, V. V., Sosa-Macias, M., Martinez, N., Roberts, J. M., & Escudero, C. (2017). Vascular dysfunction in mother and offspring during Preeclampsia: Contributions from Latin-American countries. Current Hypertension Reports, 19(10). https://doi.org/10.1007/s11906-017-0781-7

Mayrink, J., Costa, M. L., & Cecatti, J. G. (2018). Preeclampsia in 2018: Revisiting concepts, Physiopathology, and prediction. The Scientific World Journal, 2018, 1-9. https://doi.org/10.1155/2018/6268276

Lei, T., Qiu, T., Liao, W., Li, K., Lai, X., Huang, H., Yuan, R., & Chen, L. (2021). Proteinuria may be an indicator of adverse pregnancy outcomes in patients with Preeclampsia: A retrospective study. https://doi.org/10.21203/rs.3.rs-230643/v1

Ragni, M. V., Kouides, P. A., & O’Brien, S. H. (2016). Consultative hematology II: women’s health issues. American Society of Hematology Self-Assessment Program, 2016, 53-78.

Müller-Deile, J. (2014). Preeclampsia from a renal point of view: Insides into disease models, biomarkers and therapy. World Journal of Nephrology, 3(4), 169. https://doi.org/10.5527/wjn.v3.i4.169

Morris, R. K., Riley, R. D., Doug, M., Deeks, J. J., & Kilby, M. D. (2012). Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: Systematic review and meta-analysis. BMJ, 345(jul09 1), e4342-e4342. https://doi.org/10.1136/bmj.e4342

Thornton, C. E., Makris, A., Ogle, R. F., Tooher, J. M., & Hennessy, A. (2010). Role of proteinuria in defining pre‐eclampsia: Clinical outcomes for women and babies. Clinical and Experimental Pharmacology and Physiology, 37(4), 466-470. https://doi.org/10.1111/j.1440-1681.2009.05334.x

Ambia, A. M., Seasely, A. R., Macias, D. A., Nelson, D. B., Wells, C. E., McIntire, D. D., & Cunningham, F. G. (2020). The impact of baseline proteinuria in pregnant women with pregestational diabetes mellitus. American Journal of Obstetrics & Gynecology MFM, 2(1), 100072. https://doi.org/10.1016/j.ajogmf.2019.100072

Vahidi, M., Asgari, S., Tohidi, M., Azizi, F., & Hadaegh, F. (2021). Macrosomia is a risk factor for incident maternal chronic kidney disease. BMC Pregnancy and Childbirth, 21(1). https://doi.org/10.1186/s12884-021-03695-8

Wiles, K., Chappell, L., Clark, K., Elman, L., Hall, M., Lightstone, L., Mohamed, G., Mukherjee, D., Nelson-Piercy, C., Webster, P., Whybrow, R., & Bramham, K. (2019). Clinical practice guideline on pregnancy and renal disease. BMC Nephrology, 20(1). https://doi.org/10.1186/s12882-019-1560-2

Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020). Pathophysiology of type 2 diabetes mellitus. International Journal of Molecular Sciences, 21(17), 6275. https://doi.org/10.3390/ijms21176275

Mora‐Fernández, C., Domínguez‐Pimentel, V., de Fuentes, M. M., Górriz, J. L., Martínez‐Castelao, A., & Navarro‐González, J. F. (2014). Diabetic kidney disease: From physiology to therapeutics. The Journal of Physiology, 592(18), 3997-4012. https://doi.org/10.1113/jphysiol.2014.272328

Deng, L., Li, W., & Xu, G. (2021). Update on pathogenesis and diagnosis flow of normoalbuminuric diabetes with renal insufficiency. European Journal of Medical Research, 26(1). https://doi.org/10.1186/s40001-021-00612-9

Teng, J., Dwyer, K. M., Hill, P., See, E., Ekinci, E. I., Jerums, G., & MacIsaac, R. J. (2014). Spectrum of renal disease in diabetes. Nephrology, 19(9), 528-536. https://doi.org/10.1111/nep.12288

Clowse, M. E., Jamison, M., Myers, E., & James, A. H. (2008). A national study of the complications of lupus in pregnancy. American Journal of Obstetrics and Gynecology, 199(2), 127.e1-127.e6. https://doi.org/10.1016/j.ajog.2008.03.012

Hu, M., Shi, J., & Lu, W. (2022). Association between proteinuria and adverse pregnancy outcomes: A retrospective cohort study. Journal of Obstetrics and Gynaecology, 43(1). https://doi.org/10.1080/01443615.2022.2126299

Su, Y., Xie, X., Zhou, Y., Lin, H., Li, Y., Feng, N., & Luo, J. (2020). Association of induced abortion with hypertensive disorders of pregnancy risk among nulliparous women in China: a prospective cohort study. Scientific Reports, 10(1). https://doi.org/10.1038/s41598-020-61827-0

Jiang, M., Wang, Y., Fu, Q., Lin, S., Wu, J., & Di, W. (2020). Preeclampsia risk prediction model for Chinese pregnant patients with systemic lupus Erythematosus. Arthritis Care & Research, 72(11), 1602-1610. https://doi.org/10.1002/acr.24265

Zhang, S., Han, X., Liu, W., Wen, Q., & Wang, J. (2022). Pregnancy in patients with systemic lupus erythematosus: A systematic review. Archives of Gynecology and Obstetrics, 308(1), 63-71. https://doi.org/10.1007/s00404-022-06718-7